Non-invasive index for predicting significant liver fibrosis: Comparison of diagnostic performances in patients with chronic hepatitis B and C

Digestive Diseases and Sciences

Volumn 56, Issue 2, 2011, Pages 555-563

  Cheong, Jae Youn ^a   Um, Soon Ho ^b   Seo, Yeon Seok ^b   Kim, Dong Joon ^c   Hwang, Seong Gyu ^d   Lee, Youn Jae ^e   Cho, Mong ^f   Yang, Jin Mo ^g   Kim, Young Bae ^h   Park, Young Nyun ^a   Cho, Sung Won ^a  

^a Ajou University School of Medicine   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Hallym University   (South Korea)

^d CHA University   (South Korea)

^e Inje University   (South Korea)

^f Pusan National University School of Medicine   (South Korea)

^g The Catholic University of Korea   (South Korea)

^h Yonsei University College of Medicine   (South Korea)

Author keywords

Chronic hepatitis; Fibrosis marker; Liver fibrosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ALPHA 2 MACROGLOBULIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE; GELATINASE A; GLUCOSE; HAPTOGLOBIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON INVASIVE MEASUREMENT; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC;

ADULT; BIOLOGICAL MARKERS; FEMALE; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS;

EID: 79952448633     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-010-1305-3     Document Type: Article

References (32)

1. JF Perz GL Armstrong LA Farrington YJ Hutin BP Bell 2006 The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide J Hepatol 45 529 538 10.1016/j.jhep.2006.05. 013 16879891 (Pubitemid 44307383)
2. AS Lok BJ McMahon 2007 Chronic hepatitis B Hepatology 45 507 539 1:CAS:528:DC%2BD2sXisVKns7o%3D 10.1002/hep.21513 17256718 (Pubitemid 46374607)
3. MG Ghany DB Strader DL Thomas LB Seeff 2009 Diagnosis, management, and treatment of hepatitis C: an update Hepatology 49 1335 1374 1:CAS:528: DC%2BD1MXkslWjs7o%3D 10.1002/hep.22759 19330875
4. S Saadeh G Cammell WD Carey, et al. 2001 The role of liver biopsy in chronic hepatitis C Hepatology 33 196 200 1:STN:280:DC%2BD3M%2FpvV2qug%3D%3D 10.1053/jhep.2001.20534 11124836 (Pubitemid 32016902)
5. F Piccinino E Sagnelli G Pasquale G Giusti 1986 Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies J Hepatol 2 165 173 1:STN:280:DyaL287mvFGgsw%3D%3D 10.1016/S0168-8278(86)80075-7 3958472 (Pubitemid 16125908)
6. P Bedossa D Dargere V Paradis 2003 Sampling variability of liver fibrosis in chronic hepatitis C Hepatology 38 1449 1457 14647056 (Pubitemid 37466971)
7. A Regev M Berho LJ Jeffers, et al. 2002 Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection Am J Gastroenterol 97 2614 2618 10.1111/j.1572-0241.2002.06038.x 12385448
8. P Cales F Oberti S Michalak, et al. 2005 A novel panel of blood markers to assess the degree of liver fibrosis Hepatology 42 1373 1381 10.1002/hep.20935 16317693 (Pubitemid 43260040)
9. X Forns S Ampurdanes JM Llovet, et al. 2002 Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model Hepatology 36 986 992 12297848
10. F Imbert-Bismut V Ratziu L Pieroni, et al. 2001 Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study Lancet 357 1069 1075 1:CAS:528:DC%2BD3MXislGns70%3D 10.1016/S0140-6736(00) 04258-6 11297957 (Pubitemid 32322537)
11. V Leroy F Monier S Bottari, et al. 2004 Circulating matrix metalloproteinases 1, 2, 9 and their inhibitors TIMP-1 and TIMP-2 as serum markers of liver fibrosis in patients with chronic hepatitis C: comparison with PIIINP and hyaluronic acid Am J Gastroenterol 99 271 279 1:CAS:528: DC%2BD2cXitleisLk%3D 10.1111/j.1572-0241.2004.04055.x 15046217 (Pubitemid 38279869)
12. AS Lok MG Ghany ZD Goodman, et al. 2005 Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort Hepatology 42 282 292 10.1002/hep.20772 15986415 (Pubitemid 41061080)
13. RP Myers MH Tainturier V Ratziu, et al. 2003 Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B J Hepatol 39 222 230 1:CAS:528:DC%2BD3sXlsVWlu74%3D 10.1016/S0168-8278(03) 00171-5 12873819 (Pubitemid 36920558)
14. A Vallet-Pichard V Mallet B Nalpas, et al. 2007 FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection comparison with liver biopsy and fibrotest Hepatology 46 32 36 1:CAS:528:DC%2BD2sXosVyltrg%3D 10.1002/hep.21669 17567829 (Pubitemid 47171918)
15. CT Wai JK Greenson RJ Fontana, et al. 2003 A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C Hepatology 38 518 526 10.1053/jhep.2003.50346 12883497 (Pubitemid 36919874)
16. WM Rosenberg M Voelker R Thiel, et al. 2004 Serum markers detect the presence of liver fibrosis: a cohort study Gastroenterology 127 1704 1713 10.1053/j.gastro.2004.08.052 15578508 (Pubitemid 39575849)
17. MD Zeng LG Lu YM Mao, et al. 2005 Prediction of significant fibrosis in HBeAg-positive patients with chronic hepatitis B by a noninvasive model Hepatology 42 1437 1445 10.1002/hep.20960 16317674 (Pubitemid 43260048)
18. LA Adams M Bulsara E Rossi, et al. 2005 Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection Clin Chem 51 1867 1873 1:CAS:528:DC%2BD2MXhtVGmtbrL 10.1373/clinchem.2005.048389 16055434 (Pubitemid 41368177)
19. M Mohamadnejad G Montazeri A Fazlollahi, et al. 2006 Noninvasive markers of liver fibrosis and inflammation in chronic hepatitis B-virus related liver disease Am J Gastroenterol 101 2537 2545 17029616 (Pubitemid 44665250)
20. AA Bravo SG Sheth S Chopra 2001 Liver biopsy N Engl J Med 344 495 500 1:STN:280:DC%2BD3M7ksVehtw%3D%3D 10.1056/NEJM200102153440706 11172192 (Pubitemid 32164902)
21. P Bedossa T Poynard 1996 An algorithm for the grading of activity in chronic hepatitis C. The METAVIR cooperative study group Hepatology 24 289 293 1:STN:280:DyaK28zhvFClug%3D%3D 10.1002/hep.510240201 8690394 (Pubitemid 26260021)
22. ER DeLong DM DeLong DL Clarke-Pearson 1988 Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach Biometrics 44 837 845 1:STN:280:DyaL1M%2Fns12ksQ%3D%3D 10.2307/2531595 3203132
23. C Lackner G Struber B Liegl, et al. 2005 Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C Hepatology 41 1376 1382 10.1002/hep.20717 15915455 (Pubitemid 40770291)
24. L Castera J Vergniol J Foucher, et al. 2005 Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C Gastroenterology 128 343 350 10.1053/j.gastro.2004.11.018 15685546 (Pubitemid 40439195)
25. T Poynard R Morra P Halfon, et al. 2007 Meta-analyses of FibroTest diagnostic value in chronic liver disease BMC Gastroenterol 7 40 10.1186/1471-230X-7-40 17937811
26. KH Boeker CI Haberkorn D Michels, et al. 2002 Diagnostic potential of circulating TIMP-1 and MMP-2 as markers of liver fibrosis in patients with chronic hepatitis C Clin Chim Acta 316 71 81 1:CAS:528:DC%2BD3MXpt1amsLY%3D 10.1016/S0009-8981(01)00730-6 11750276 (Pubitemid 34028190)
27. RC Benyon JP Iredale S Goddard PJ Winwood MJ Arthur 1996 Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver Gastroenterology 110 821 831 1:CAS:528:DyaK28XhvFCmtbY%3D 10.1053/gast.1996.v110.pm8608892 8608892 (Pubitemid 26071850)
28. AE Kossakowska DR Edwards SS Lee, et al. 1998 Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis Am J Pathol 153 1895 1902 1:CAS:528:DyaK1cXotV2rsrs%3D 9846979 (Pubitemid 28550676)
29. T Poynard M Munteanu F Imbert-Bismut, et al. 2004 Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C Clin Chem 50 1344 1355 1:CAS:528:DC%2BD2cXmtFKgu74%3D 10.1373/clinchem.2004.032227 15192028 (Pubitemid 38970641)
30. RA Standish E Cholongitas A Dhillon AK Burroughs AP Dhillon 2006 An appraisal of the histopathological assessment of liver fibrosis Gut 55 569 578 1:STN:280:DC%2BD287kt1Gitg%3D%3D 10.1136/gut.2005.084475 16531536
31. D Cassiman T Roskams 2002 Beauty is in the eye of the beholder: emerging concepts and pitfalls in hepatic stellate cell research J Hepatol 37 527 535 10.1016/S0168-8278(02)00263-5 12217608
32. M Kojiro K Shimamatsu M Kage 1995 Pathomorphologic comparison of hepatitis C virus-related and hepatitis B virus-related cirrhosis bearing hepatocellular carcinoma Princess Takamatsu Symp 25 179 184 1:STN:280: DyaK2s%2FivFKisQ%3D%3D 8875623